Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

QNCXQNCX

Showing 3 of 6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in QUINCE THERAPEUTICS INC

As of its Q1 2026 13F, Goldman Sachs Group held 16,064 shares of QNCX (Quince Therapeutics), worth $1,629. Goldman Sachs Group's 13F filings listed QNCX from Q4 2025 to Q1 2026, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$769,478

Total Shares Change

-229,695

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$18.19
0
2026-Q1
Decreased
16,064
-93.0%
$1,6290.0%$20.20
0
2025-Q4
New
229,695
—
$769,4780.0%$670.00
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used